Global Drug-Eluting Stents Sales Market Report 2016

December 2016 | 107 pages | ID: GEA2E2F45D1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drug-Eluting Stents

Revenue, means the sales value of Drug-Eluting Stents

This report studies sales (consumption) of Drug-Eluting Stents in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Abbott Vascular (USA)
• Boston Scientific, Inc. (USA)
• Biosensors International Pte Ltd. (Singapore)
• Medtronic, Inc.(USA)
• MIV Therapeutics, Inc. (Canada)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Drug-Eluting Stents in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Drug-Eluting Stents in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Drug-Eluting Stents Sales Market Report 2016

1 DRUG-ELUTING STENTS OVERVIEW

1.1 Product Overview and Scope of Drug-Eluting Stents
1.2 Classification of Drug-Eluting Stents
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Drug-Eluting Stents
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Drug-Eluting Stents Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Drug-Eluting Stents (2011-2021)
  1.5.1 Global Drug-Eluting Stents Sales and Growth Rate (2011-2021)
  1.5.2 Global Drug-Eluting Stents Revenue and Growth Rate (2011-2021)

2 GLOBAL DRUG-ELUTING STENTS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Drug-Eluting Stents Market Competition by Manufacturers
  2.1.1 Global Drug-Eluting Stents Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Drug-Eluting Stents Revenue and Share by Manufacturers (2011-2016)
2.2 Global Drug-Eluting Stents (Volume and Value) by Type
  2.2.1 Global Drug-Eluting Stents Sales and Market Share by Type (2011-2016)
  2.2.2 Global Drug-Eluting Stents Revenue and Market Share by Type (2011-2016)
2.3 Global Drug-Eluting Stents (Volume and Value) by Regions
  2.3.1 Global Drug-Eluting Stents Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Drug-Eluting Stents Revenue and Market Share by Regions (2011-2016)
2.4 Global Drug-Eluting Stents (Volume) by Application

3 UNITED STATES DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Drug-Eluting Stents Sales and Value (2011-2016)
  3.1.1 United States Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  3.1.2 United States Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  3.1.3 United States Drug-Eluting Stents Sales Price Trend (2011-2016)
3.2 United States Drug-Eluting Stents Sales and Market Share by Manufacturers
3.3 United States Drug-Eluting Stents Sales and Market Share by Type
3.4 United States Drug-Eluting Stents Sales and Market Share by Application

4 CHINA DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

4.1 China Drug-Eluting Stents Sales and Value (2011-2016)
  4.1.1 China Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  4.1.2 China Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  4.1.3 China Drug-Eluting Stents Sales Price Trend (2011-2016)
4.2 China Drug-Eluting Stents Sales and Market Share by Manufacturers
4.3 China Drug-Eluting Stents Sales and Market Share by Type
4.4 China Drug-Eluting Stents Sales and Market Share by Application

5 EUROPE DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Drug-Eluting Stents Sales and Value (2011-2016)
  5.1.1 Europe Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  5.1.2 Europe Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Drug-Eluting Stents Sales Price Trend (2011-2016)
5.2 Europe Drug-Eluting Stents Sales and Market Share by Manufacturers
5.3 Europe Drug-Eluting Stents Sales and Market Share by Type
5.4 Europe Drug-Eluting Stents Sales and Market Share by Application

6 JAPAN DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Drug-Eluting Stents Sales and Value (2011-2016)
  6.1.1 Japan Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  6.1.2 Japan Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Drug-Eluting Stents Sales Price Trend (2011-2016)
6.2 Japan Drug-Eluting Stents Sales and Market Share by Manufacturers
6.3 Japan Drug-Eluting Stents Sales and Market Share by Type
6.4 Japan Drug-Eluting Stents Sales and Market Share by Application

7 GLOBAL DRUG-ELUTING STENTS MANUFACTURERS ANALYSIS

7.1 Abbott Vascular (USA)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Drug-Eluting Stents Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Abbott Vascular (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Boston Scientific, Inc. (USA)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 107 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Boston Scientific, Inc. (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Biosensors International Pte Ltd. (Singapore)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 123 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Medtronic, Inc.(USA)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Medtronic, Inc.(USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 MIV Therapeutics, Inc. (Canada)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview

8 DRUG-ELUTING STENTS MAUFACTURING COST ANALYSIS

8.1 Drug-Eluting Stents Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Drug-Eluting Stents

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Drug-Eluting Stents Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Drug-Eluting Stents Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL DRUG-ELUTING STENTS MARKET FORECAST (2016-2021)

12.1 Global Drug-Eluting Stents Sales, Revenue Forecast (2016-2021)
12.2 Global Drug-Eluting Stents Sales Forecast by Regions (2016-2021)
12.3 Global Drug-Eluting Stents Sales Forecast by Type (2016-2021)
12.4 Global Drug-Eluting Stents Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drug-Eluting Stents
Table Classification of Drug-Eluting Stents
Figure Global Sales Market Share of Drug-Eluting Stents by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Drug-Eluting Stents
Figure Global Sales Market Share of Drug-Eluting Stents by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure China Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure Europe Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure Japan Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure Global Drug-Eluting Stents Sales and Growth Rate (2011-2021)
Figure Global Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Table Global Drug-Eluting Stents Sales of Key Manufacturers (2011-2016)
Table Global Drug-Eluting Stents Sales Share by Manufacturers (2011-2016)
Figure 2015 Drug-Eluting Stents Sales Share by Manufacturers
Figure 2016 Drug-Eluting Stents Sales Share by Manufacturers
Table Global Drug-Eluting Stents Revenue by Manufacturers (2011-2016)
Table Global Drug-Eluting Stents Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Drug-Eluting Stents Revenue Share by Manufacturers
Table 2016 Global Drug-Eluting Stents Revenue Share by Manufacturers
Table Global Drug-Eluting Stents Sales and Market Share by Type (2011-2016)
Table Global Drug-Eluting Stents Sales Share by Type (2011-2016)
Figure Sales Market Share of Drug-Eluting Stents by Type (2011-2016)
Figure Global Drug-Eluting Stents Sales Growth Rate by Type (2011-2016)
Table Global Drug-Eluting Stents Revenue and Market Share by Type (2011-2016)
Table Global Drug-Eluting Stents Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drug-Eluting Stents by Type (2011-2016)
Figure Global Drug-Eluting Stents Revenue Growth Rate by Type (2011-2016)
Table Global Drug-Eluting Stents Sales and Market Share by Regions (2011-2016)
Table Global Drug-Eluting Stents Sales Share by Regions (2011-2016)
Figure Sales Market Share of Drug-Eluting Stents by Regions (2011-2016)
Figure Global Drug-Eluting Stents Sales Growth Rate by Regions (2011-2016)
Table Global Drug-Eluting Stents Revenue and Market Share by Regions (2011-2016)
Table Global Drug-Eluting Stents Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Drug-Eluting Stents by Regions (2011-2016)
Figure Global Drug-Eluting Stents Revenue Growth Rate by Regions (2011-2016)
Table Global Drug-Eluting Stents Sales and Market Share by Application (2011-2016)
Table Global Drug-Eluting Stents Sales Share by Application (2011-2016)
Figure Sales Market Share of Drug-Eluting Stents by Application (2011-2016)
Figure Global Drug-Eluting Stents Sales Growth Rate by Application (2011-2016)
Figure United States Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure United States Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure United States Drug-Eluting Stents Sales Price Trend (2011-2016)
Table United States Drug-Eluting Stents Sales by Manufacturers (2011-2016)
Table United States Drug-Eluting Stents Market Share by Manufacturers (2011-2016)
Table United States Drug-Eluting Stents Sales by Type (2011-2016)
Table United States Drug-Eluting Stents Market Share by Type (2011-2016)
Table United States Drug-Eluting Stents Sales by Application (2011-2016)
Table United States Drug-Eluting Stents Market Share by Application (2011-2016)
Figure China Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure China Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure China Drug-Eluting Stents Sales Price Trend (2011-2016)
Table China Drug-Eluting Stents Sales by Manufacturers (2011-2016)
Table China Drug-Eluting Stents Market Share by Manufacturers (2011-2016)
Table China Drug-Eluting Stents Sales by Type (2011-2016)
Table China Drug-Eluting Stents Market Share by Type (2011-2016)
Table China Drug-Eluting Stents Sales by Application (2011-2016)
Table China Drug-Eluting Stents Market Share by Application (2011-2016)
Figure Europe Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure Europe Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure Europe Drug-Eluting Stents Sales Price Trend (2011-2016)
Table Europe Drug-Eluting Stents Sales by Manufacturers (2011-2016)
Table Europe Drug-Eluting Stents Market Share by Manufacturers (2011-2016)
Table Europe Drug-Eluting Stents Sales by Type (2011-2016)
Table Europe Drug-Eluting Stents Market Share by Type (2011-2016)
Table Europe Drug-Eluting Stents Sales by Application (2011-2016)
Table Europe Drug-Eluting Stents Market Share by Application (2011-2016)
Figure Japan Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure Japan Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure Japan Drug-Eluting Stents Sales Price Trend (2011-2016)
Table Japan Drug-Eluting Stents Sales by Manufacturers (2011-2016)
Table Japan Drug-Eluting Stents Market Share by Manufacturers (2011-2016)
Table Japan Drug-Eluting Stents Sales by Type (2011-2016)
Table Japan Drug-Eluting Stents Market Share by Type (2011-2016)
Table Japan Drug-Eluting Stents Sales by Application (2011-2016)
Table Japan Drug-Eluting Stents Market Share by Application (2011-2016)
Table Abbott Vascular (USA) Basic Information List
Table Abbott Vascular (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Vascular (USA) Drug-Eluting Stents Global Market Share (2011-2016)
Table Boston Scientific, Inc. (USA) Basic Information List
Table Boston Scientific, Inc. (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boston Scientific, Inc. (USA) Drug-Eluting Stents Global Market Share (2011-2016)
Table Biosensors International Pte Ltd. (Singapore) Basic Information List
Table Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Global Market Share (2011-2016)
Table Medtronic, Inc.(USA) Basic Information List
Table Medtronic, Inc.(USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medtronic, Inc.(USA) Drug-Eluting Stents Global Market Share (2011-2016)
Table MIV Therapeutics, Inc. (Canada) Basic Information List
Table MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug-Eluting Stents
Figure Manufacturing Process Analysis of Drug-Eluting Stents
Figure Drug-Eluting Stents Industrial Chain Analysis
Table Raw Materials Sources of Drug-Eluting Stents Major Manufacturers in 2015
Table Major Buyers of Drug-Eluting Stents
Table Distributors/Traders List
Figure Global Drug-Eluting Stents Sales and Growth Rate Forecast (2016-2021)
Figure Global Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Table Global Drug-Eluting Stents Sales Forecast by Regions (2016-2021)
Table Global Drug-Eluting Stents Sales Forecast by Type (2016-2021)
Table Global Drug-Eluting Stents Sales Forecast by Application (2016-2021)